Advanced

RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

Lilljebjörn, Henrik LU ; Ågerstam, Helena LU ; Orsmark Pietras, Christina LU ; Rissler, Marianne LU ; Ehrencrona, Hans LU ; Nilsson, L; Richter, Johan LU and Fioretos, Thoas LU (2014) In Leukemia 28(4). p.977-979
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Leukemia
volume
28
issue
4
pages
977 - 979
publisher
Nature Publishing Group
external identifiers
  • pmid:24186003
  • wos:000334350900039
  • scopus:84898466517
ISSN
1476-5551
DOI
10.1038/leu.2013.324
language
English
LU publication?
yes
id
cc10e79d-3486-4765-962c-add6d364c8bf (old id 4179849)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24186003?dopt=Abstract
date added to LUP
2013-12-04 20:56:28
date last changed
2017-10-01 03:22:46
@article{cc10e79d-3486-4765-962c-add6d364c8bf,
  author       = {Lilljebjörn, Henrik and Ågerstam, Helena and Orsmark Pietras, Christina and Rissler, Marianne and Ehrencrona, Hans and Nilsson, L and Richter, Johan and Fioretos, Thoas},
  issn         = {1476-5551},
  language     = {eng},
  number       = {4},
  pages        = {977--979},
  publisher    = {Nature Publishing Group},
  series       = {Leukemia},
  title        = {RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.},
  url          = {http://dx.doi.org/10.1038/leu.2013.324},
  volume       = {28},
  year         = {2014},
}